Dr. Ken Dretchen Appointed to PhRMA Review Committee
November 9, 2017 Dr. Ken Dretchen, Chief Scientific Officer served as a member of the Basic Pharmacology Advisory Committee for…
November 9, 2017 Dr. Ken Dretchen, Chief Scientific Officer served as a member of the Basic Pharmacology Advisory Committee for…
June 14, 2017 During the week beginning Sunday 6/11/17 Michael Mesa , President of Mesa Science Associates , will represent…
April 12, 2017 Mesa Science Associates (MSA) announced today, April 12, 2017 plans to join Counter Act researchers and scientists…
November 8, 2016 Recently, Michael Mesa, MSA President and CEO, was invited by Dr. Adrianne Noe , the curator of…
November 4, 2016 Dr. Ken Dretchen, Chief Scientific Officer served as a member of the Basic Pharmacology Advisory Committee for…
September 2, 2016 Press Release Mesa Science Associates, Inc. Receives 2016 Best of Frederick Award Frederick Award Program Honors the…
August 26, 2016 Last fall, I started as an intern for the pharmaceutical development consulting firm Mesa Science Associates (MSA)…
July 26, 2016 The Science Advisory Board invites Dr. Ken Dretchen to join a global community of scientific professionals to collaborate on…
May 24, 2016 Dr. Kenneth Dretchen gave the Commencement Address on May 20, 2016 at Georgetown University to the students…
May 12, 2016 On the evening of May 4, 2016 Mr. Michael Mesa, President and CEO of two Frederick MD…
FREDERICK, MD. Nov. 10, 2022—MesaGreen Pharmaceutical Company announced today that the company has filed an Investigational New Animal Drug (INAD)…
Mesa Science Associates Inc. (MSA) received a Phase I Small Business Innovative Research Grant (SBIR) from the National Institutes of…
Mesa Science Associates has applied for an NIH Small Business Innovative Research (SBIR) Grant from the National Institutes of Health…